The aim of this study is to describe the epidemiological, clinical,
biological profile, etiology and management of erysipelas in pediatric
emergency departments. In this retrospective study carried out over a period of
12 months, we identified 20 cases of erysipelas, with an incidence of 2%, and a
female predominance of 65% of cases. Ageaverage patient age was 6
years, and the average consultation time was 5 days. The Diagnosis of
erysipelas is mainly based on clinical features, including the presence of
erythema associated with inflammatory signs, which were present in allcases.
Satellite lymphadenopathy was observed in five cases, and fever was present in
all patients. The therapeutic approach is mainly based on the administrationof injectable antibiotics in children, using amoxicillin-clavulanate dose
of 80 mg/kg/day in three doses.
References
[1]
Jait, N. (2015) Erysipèle chez l’enfant: Diagnostic et traitement. These, Université Mohamed V, Rabat.
[2]
Bernard, P. (1992) Dermo-Hypodermal Bacterial Infections: Current Concepts. European Journal of Medicine, 1, 97-104.
[3]
Goettsch, W.G., Bouwes Bavinck, J.N. and Herings, R.M. (2006) Burden of Illness of Bacterial Cellulites and Erysipelas of the Leg in the Netherlands. Journal of the European Academy of Dermatology and Venereology, 20, 834-835.
https://doi.org/10.1111/j.1468-3083.2006.01657.x
[4]
Kacem, I., Habboul, Z., Kortas, H., Guedria, A., Mejaouel, H., Hmidi, N., Mlika, A., Khammeri, S. and Ben Helel, K. (2012) Erysipele Du Nourrison Et De L’enfant: à propos de 30 cas Service de pédiatrie de l’hôpital régional de Kairouan.
[5]
Douhi, Z., Meziane, M., Bouzidi, H., Amraoui, N., Gallouj, S., Mikou, O., Mernissi, F. and Hida, M. (2018) Erysipèle chez l’enfant: à propos de 11 cas pédiatriques Service dedermatologie-vénéréologie, CHU Hassan II Fès, Maroc. La société Marocaine de dermatologie pédiatrique. Le congrès national de dermatologie pédiatrique. Les 16-17. http://www.smdermato.org/ancien%20siteweb/revue3/RMD%203.pdf
[6]
Del Guidice, P., Tattevin, P. and Etienne, J. (2012) Infections à Staphylococcus aureus résistants à la meticilline communautaires. La Presse Médicale, 41, 713-720.
https://doi.org/10.1016/j.lpm.2011.10.022
[7]
Crickx, B., Chevron, F., Sigal-Nahum, M., Bilet, S., Faucher, F., Picard, C., et al. (1991) érysipèle: Données épidémiologiques cliniques et thérapeutiques. Annales de Dermatologie et de Vénéréologie, 118, 11-16.
[8]
Lorette, G., Vaillant, L. and Baulieu, F. (2001) Lymphœdèmes de l’enfant. Annales de Dermatologie et de Vénéréologie, 128, 674-676.
[9]
Dupuy, A., Benchikhi, H., Roujeau, J.C., Bernard, P., Vaillant, L., Chosidow, O., et al. (1999) Risk Factors for Erysipelas of the Leg (Cellulitis): Case-Control Study. British Medical Journal, 318, 1591-1594. https://doi.org/10.1136/bmj.318.7198.1591
[10]
Mokni, M., Dupuy, A., Denguezli, M., Dhaoui, R., Bouassida, S., Amri, M., et al. (2006) Risk Factors for Erysipelas of the Leg in Tunisia: A Multicenter Case-Control Study. Dermatology, 212, 108-112. https://doi.org/10.1159/000090649
[11]
Jégou, J., Hansmann, Y., Chalot, F., Roger, M., Faivre, B., Granel, F., et al. (2002) Hospitalization Criteria for Erysipelas: Prospective Study in 145 Cases. Annales de Dermatologie et de Vénéréologie, 129, 375-379.
[12]
Moulin, F., Quinet, B., Raymond, J., et al. (2008) Propositions thérapeutiques pour le traitement des infections cutanées bactériennes. Archives de Pédiatrie, 15, S62-S67. https://doi.org/10.1016/S0929-693X(08)74218-0
[13]
Ronnen, M., Suster, S., Schewach-Millet, M. and Modan, M. (1985) Erysipelas. Changing Faces. International Journal of Dermatology, 24, 169-172.
https://doi.org/10.1111/j.1365-4362.1985.tb05750.x
[14]
Chartier, C. and Grosshans, E. (1990) Erysipelas. International Journal of Dermatology, 29, 459-467. https://doi.org/10.1111/j.1365-4362.1990.tb04833.x
[15]
Larru, B. and Gerber, J.S. (2014) Cutaneous Bacterial Infections Caused by Staphylococcus aureus and Streptococcus pyogenes in Infants and Children. Pediatric Clinics of North America, 61, 457-478. https://doi.org/10.1016/j.pcl.2013.12.004
[16]
Daniel, R. (1991) Azithromycin, Erythromycin and Cloxacillin in the Treatment of Infections of Skin and Associated Soft Tissues. Journal of International Medical Research, 19, 433-435. https://doi.org/10.1177/030006059101900602
[17]
Pichichero, M.E. (2005) A Review of Evidence Supporting the American Academy of Pediatrics Recommendation for Prescribing Cephalosporin Antibiotics in Penicillin-Allergic Patients. Pediatrics, 115, 1048-1057.
https://doi.org/10.1542/peds.2004-1276
